Spun out from, and grounded in work initially patented by Duke University, Affinergy, LLC develops site-specific biological systems using biofriendly linkers that selectively adhere to proteins, drugs, cells, and biomaterial surfaces to kickstart biology toward an intended outcome. For some time incubated at the Becton Dickinson's research center in Research Triangle Park, Affinergy is focused on developing coatings and medical devices for the orthopedic and cardiovascular markets.develops products that purify, concentrate, and remove cells and proteins from tissues and fluids for diagnostic and research applications. It develops a phage display platform that identifies peptides that bind to a variety of targets, such as drugs, proteins, and cells. The companys products also include implantable devices that deliver and retain biologics at the site of implant in orthopedic procedures and soft tissue repair.
